FDA Review posts the Federal Register notices for the week ending 8/18/2017.
FDA provides guidance to Ritter Pharmaceuticals for it to begin a Phase 3 trial for RP-G28 for treating lactose intolerance.
Vital Rx (dba Atlantic Pharmacy and Compounding) recalls all lots of all compounded injectable prescription medications after a recent FDA inspection ...
FDA issues a draft guidance on Identifying Trading Partners Under the Drug Supply Chain Security Act that explains requirements for the various types ...
FDA announces three upcoming generic drug development workshops in October.
FDAs Office of Orphan Products Development awards Protalex a $403,000 grant to support future clinical development activity of PRTX-100 as a treatment...
FDA announces the availability of a public docket for submitting comments about the development of recommendations regarding the content of risk infor...
Bella Pharmaceuticals recalls all lots of unexpired sterile drug products due to lack of sterility assurance.